REFERENCES
- Mehta TS, Raza S. Power Doppler sonography of breast cancer: does vascularity correlate with node status or lymphatic vascular invasion? Am J Roentgenol. 1999;173:303–307.
- Pinder SE, Ellis IO, Galea M, O'Rourke S, Blamey RW, Elston CW. Pathological prognostic factors in breast cancer, III: vascular invasion—relationship with recurrence and survival in a large study with long-term follow-up. Histopathology. 1994;24:41–47.
- Azmy IAF, Balasubramanian SP, Wilson AG, et al. Role of tumour necrosis factor gene polymorphisms (−308 and −238) in breast cancer susceptibility and severity. Breast Cancer Res. 2004;6:R395–R400.
- Ghilard G, Blondi ML, Caccini F, de Monti M, Guagnellini E, Scorza R. Vascular invasion in human breast cancer is correlated to T→786 polymorphism of NOS3 gene. Nitric Oxide. 2003;9:118–122.
- Hahnel R, Harvey J, Robbins P, Sterrett G. Cathepsin-D in human breast cancer: correlation with vascular invasion and other clinical and histopathological characteristics. Anticancer Res. 1993;13:2131–2135.
- Van den Eynden G, Van der Auera I, Van Laere SJ, et al. Distinguishing blood and lymph vessel invasion in breast cancer: a prospective immunohistochemical study. Br J Cancer. 2006;94:1643–1649.
- Westened PJ, Meurs GJG, Damhuis RAM. Tumor size and vascular invasion predict distant metastasis in stage I breast cancer: grade distinguishes early and late metastasis. J Clin Pathol. 2005;58:196–201.
- Colleoni M, Rotmensz N, Maisonneuve P, et al. Prognostic role of the extent of peritumoral vascular invasion in operable breast cancer. Ann Oncol. 2007;18:1632–1640.
- Mathoulin-Portier MP, Meynard P, Charton-Bain MC, et al. Peritumoral vascular invasion in women with node- negative breast cancer, receiving no adjuvant therapy. Anticancer Res. 1999;19:843–847.
- Dua RS, Gui GP, Isacke CM. Endothelial adhesion molecules in breast cancer invasion into the vascular and lymphatic systems. Eur J Surg Oncol. 2005;31:824–832.
- Hope S. Rugo. Bevacizumab in the treatment of breast cancer: Rationale and current data. The Oncologist. 2004;9 (Suppl 1): 43–49.
- Scott LJ. Bevacizumab: in first-line treatment of metastatic breast cancer. Drugs. 2007;67:1793–1799.
- Voloudakis GE, Baltatzis GE, Stefanou D, Agnantis NJ, Voloudakis-Baltatzis I. Surface topography and ultrastructure correlation between human breast infiltrating ductal carcinoma of non special type and coexisting human breast infiltrating ductal carcinoma of non special type with in situ comedo carcinoma. BUON. 2003;8:151–156.